Intra-and inter-operator repeatability of myocardial blood flow and myocardial flow reserve measurements using rubidium-82 pet and a highly automated analysis program

Journal of Nuclear Cardiology

Volumn 17, Issue 4, 2010, Pages 600-616

  Klein, Ran ^a   Renaud, Jennifer M ^a   Ziadi, Maria C ^a   Thorn, Stephanie L ^a   Adler, Andy ^b   Beanlands, Rob S ^a   DeKemp, Robert A ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CARLETON UNIVERSITY   (Canada)

Author keywords

Coronary blood flow; Image processing; Operator repeatability; PET; Rubidium 82

Indexed keywords

DIPYRIDAMOLE; RUBIDIUM 82;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; DIAGNOSTIC VALUE; FEMALE; HEART LEFT VENTRICLE; HEART MUSCLE BLOOD FLOW; HUMAN; MALE; OBSERVER VARIATION; PHARMACOLOGIC STRESS TESTING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; REST;

EID: 77956539101     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-010-9225-3     Document Type: Article

References (52)

1. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, et al. Heart disease and stroke statistics-2006 update. Circulation 2006;113: e85-151.
2. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global burden of disease study. Lancet 1997;349:1436-42.
3. Gulati M, Pandey DK, Arnsdorf MF, Lauderdale DS, Thisted RA, Wicklund RH, et al. Exercise capacity and the risk of death in women. Circulation 2003;108:1554-9.
4. Yoshida K, Mullani N, Gould KL. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med 1996;37:1701-12.
5. Gould KL. Quantification of coronary artery stenosis in vivo. Circ Res 1985;57:341-53.
6. Parkash R, deKemp RA, Ruddy TD, Kitsikis A, Hart R, Beauschene L, et al. Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol 2004;11:440-9.
7. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990;15:1032-42.
8. Gerwitz H, Skopicki HA, Abraham SA, Castano H, Dinsmore RE, Alpert NM, et al. Quantitative PET measurements of regional myocardial blood flow: Observations in humans with ischemic heart disease. Cardiology 1997;88:62-70.
9. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 1994;90:808-17.
10. Yoshinaga K, Tamaki N, Ruddy TD, deKemp RA, Beanlands RSB. Evaluation of myocardial perfusion. In: Wahl RL, editor. Principles and practice of PET and PET/CT, 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009. p. 541-64.
11. Schindler TH, Nitzsche EU, Schelbert HR, Olschewski M, Sayre J, Mix M, et al. Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. J Am Coll Cardiol 2005;45:1505-12.
12. deKemp RA, Ruddy TD, Hewitt T, Dalipaj MM, Beanlands RSB. Detection of serial changes in absolute myocardial perfusion with 82Rb PET. J Nucl Med 2000;41:1426-35.
13. Kaufmann PA, Camici PG. Myocardial blood flow measurements by PET: Technical aspects and clinical applications. J Nucl Med 2005;46:75-88.
14. Yoshinaga K, Chow BJW, Williams K, Chen L, deKemp RA, Garrard L, et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography. J Am Coll Cardiol 2006;48:1029-39.
15. Tio RA, Dabeshlim A, Siebelink HMJ, de Sutter J, Hillege HL, Zeebregts CJ, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 2009;50:214-9.
16. Lautamäki R, George RT, Kitagawa K, Higuchi T, Merrill J, Voicu C, et al. Rubidium-82 PET-CT for quantitative assessment of myocardial blood flow: validation in a canine model of coronary artery stenosis. Eur J Nucl Med Mol Imaging 2009;36:576-86.
17. deKemp RA, Klein R, Renaud JM, Alghamdi A, Lortie M, DaSilva J, et al. 3D listmode cardiac PET for simultaneous quantification of myocardial blood flow and ventricular function. IEEE NSS-MIC Conference Record 2008:5215-8.
18. Lortie M, Beanlands RSB, Yoshinaga K, Klein R, DaSilva JN, deKemp RA. Quantification of myocardial blood flow with 82Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging. 2007;34:1765-74.
19. Manabe O, Yoshinaga K, Katoh C, Naya M, de Kemp RA, Tamaki N. Repeatability of rest and hyperemic myocardial blood flow measurements with 82Rb dynamic PET. J Nucl Med 2009;50:68-71.
20. Merhige ME, Breen WJ, Shelton V, Houston T, D'Arcy BJ, Perna AF. Impact of myocardial perfusion imaging with PET and (82) Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management. J Nucl Med 2007;48:1069-76.
21. Alvarez-Diez TM, deKemp RA, Beanlands RS Vincent J. Manufacture of strontium-82/rubidium-82 generators and quality control of rubidium-82 chloride for myocardial perfusion imaging in patients using positron emission tomography. Appl Radiat Isot 1999;50:1015-23.
22. Klein R, Adler A, Beanlands RS, deKemp RA. Precision-controlled elution of a 82Sr/82Rb generator for cardiac perfusion imaging with positron emission tomography. Phys Med Biol 2007;52:659-73.
23. deKemp R, Klein R, Lortie M, Beanlands R. Constant-activity-rate infusions for myocardial blood flow quantification with 82Rb and 3D PET. IEEE NSS-MIC Conference Record 2006;6:3519-21.
24. Lammertsma AA. Myocardial perfusion in 3 dimensions. J Nucl Med 2002;48:1041-3.
25. deKemp RA, Yoshinaga K, Beanlands RSB. Will 3-dimensional PET-CT enable the routine quantification of myocardial blood flow. J Nucl Cardiol 2007;14:380-97.
26. Buckberg GD, Luck JC, Payne DB, Hoffman JIE, Archie JP, Fixler DE. Some sources of error in measuring regional blood flow with radioactive microspheres. J Appl Physiol 1971;31:598-604.
27. Herrero P, Kim J, Sharp TL, Engelbach JA, Lewis JS, Gropler RJ, et al. Assessment of myocardial blood flow using 15O-water and 1-11C-acetate in rats with small-animal PET. J Nucl Med 2006;47:477-85.
28. Mullani NA, Goldstein RA, Gould KL, Marani SK, Fisher DJ, O'Brien HA, et al. Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors. J Nucl Med 1983;24:898-906.
29. DeGrado TR, Hanson MW, Turkington TG, Delong DM, Brezinski DA, Vallée JP, et al. Estimation of myocardial blood flow for longitudinal studies with 13 N-labeled ammonia and positron emission tomography. J Nucl Med 1996;3:494-507.
30. El Fakhri G, Kardan A, Sitek A, Dorbala S, Abi-Hatem N, Lahoud Y, et al. Reproducibility and accuracy of quantitative myocardial blood flow assessment with 82Rb PET: Comparison with 13N-ammonia PET. J Nucl Med 2009;50:1062-71.
31. Chareonthaitawee P, Christenson SD, Anderson JL, Kemp BJ, Hodge DO, Ritman EL, et al. Reproducibility of measurements of regional myocardial blood flow in a model of coronary artery disease: Comparison of H2 15O and 13 NH3 PET techniques. J Nucl Med 2006;47:1193-201.
32. Scott NS, Le May MR, deKemp RA, Ruddy TD, Labinaz M, Marquis JF, et al. Evaluation of myocardial perfusion using rubidium-82 positron emission tomography after myocardial infarction in patients receiving primary stent implantation or thrombolytic therapy. Am J Cardiol 2001;88:886-9.
33. Sawada S, Muzik O, Beanlands RS, Wolfe E, Hutchins GD, Schwaiger M. Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen 13 ammonia-labeled positron emission tomography. J Nucl Med 1995;2:413-22.
34. Nagamachi S, Czernin J, Kim AS, Sun KT, Böttcher M, Phelps ME, et al. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med 1996;37:1626-31.
35. Kaufmann PA, Gnecchi-Ruscone T, Yap JT, Rimoldi O, Camici PG. Assessment of reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. J Nucl Med 1999;40:1848-56.
36. Katoh C, Morita K, Shiga T, Kubo N, Nakada K, Tamaki N. Improvement of algorithm for quantification of regional myocardial blood flow using 15O-water with PET. J Nucl Med 2004;45:1908-16.
37. Jagathesan R, Kaufmann PA, Rosen SD, Rimoldi OE, Turkeimer F, Foale R, et al. Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease. J Nucl Med 2005;46:212-9.
38. Wyss CA, Koepfli P, Mikolajczyk K, Burger C, von Schulthess GK, Kaufmann PA. Bicycle exercise stress in PET for assessment of coronary flow reserve-repeatability and comparison with adenosine stress. J Nucl Med 2003;44:146-54.
39. ™). Eur J Nucl Med Mol Imaging 2009;36:1594-602.
40. Knešaurek K, Machac J, Zhang Z. Repeatability of regional myocardial blood flow calculation in 82Rb PET imaging. BMC Med Phys 2009;9:2.
41. Schindler TH, Zhang XL, Prior JO, Cadenas J, Dahlbom M, Sayre J, et al. Assessment of intra-and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with 13N-ammonia and PET. Eur J Nucl Med Mol Imaging 2007;34:1178-88.
42. Adachi I, Gaemperli O, Valenta I, Schepis T, Siegrist PT, Treyer V, et al. Assessment of myocardial perfusion by dynamic O-15-labeled water PET imaging: Validation of a new fast factor analysis. J Nucl Cardiol 2007;14:698-705.
43. Germano G, Kavanagh PB, Su HT, Mazzanti M, Kiat H, Hachamovitch R, et al. Automatic reorientation of three-dimensional, transaxial myocardial perfusion SPECT images. J Nucl Med 1995;36:1107-14.
44. PMOD Technologies (Online). http://www.pmod.com.
45. Nekolla SG, Miethaner C, Nguyen N, Ziegler SI, Schwaiger M. Reproducibility of polar map generation and assessment of defect severity and extent in myocardial perfusion imaging using postiron emission tomography. Eur J Nucl Med 1998;25:1313-21.
46. Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Gropler RJ, et al. 2009, July. http://www.asnc.org.
47. Gerwitz H, Fischman AJ, Abraham S, Gilson M, Strauss HW, Alpert NM. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol 1994;23:851-9.
48. Renkin EM. Transport of potassium-42 from blood to tissue isolated mammalian skeletal muscles. Am J Physiol 1959;197:1205-10.
49. Crone C. Permeability of capillaries in various organs as determined by use of the indicator diffusion method. Acta Physiol Scand 1963;58:292-305.
50. Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. Statistician 1983:307-17.
51. Austin RE, Aldea GS, Coggins DL, Flynn AE, Hoffman JIE. Profound spatial heterogeneity of coronary reserve-Discordance between patterns of resting and maximal myocardial blood flow. Circ Res 1990;67:319-31.
52. Chareonthaitawee P, Kaufmann PA, Rimoldi O, Camici PG. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Circ Res 2001;50:151-61.